Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-137-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-02-16"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"sk"^^xsd:language2
lpv:document identification number	"en.20110216.11.3-137-000"2
lpv:hasSubsequent	lp_eu:2011-02-16-Speech-3-138-0002
lpv:speaker	lp:Sergej Kozlík2
lpv:spokenAs	member; BUDG (2009-07-16--2012-01-18)3 substitute; ECON (2009-07-16--2011-05-12)3 unknown; Ľudová strana - Hnutie za demokratické Slovensko (2009-07-14--2014-03-19)3 member; Delegation to the EU-Russia Parliamentary Cooperation Committee (2009-09-16--2014-06-30)3 member_of_the_bureau; ALDE (2009-07-20--2014-06-30)3
lpv:translated text	"Mr President, according to estimates, about 1% of the overall volume of medicines supplied to patients legally through the pharmacy network in the EU today are fake. That percentage is constantly rising. This is about people’s health. Fake medicines may have effects other than those of the tablets prescribed by the doctor. They may also be a risk to health. Counterfeiting is a crime and must carry specific penalties. The new legislation, which I support, introduces more safety elements, as well as penalties for counterfeiters. It defines a monitoring system improving the identification of medicines, so that in future the flow of medicines can be traced all the way from the producer to the consumer. The sale of medicines via the Internet is also included within the framework of the new rules. This represents one of the most common ways for fake products to get onto EU markets."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph